COVID-19 Lab Tests: HHS Withdraws Policy Limiting FDA’s Review, and FDA Issues an Updated Policy Requiring EUAs
FDA Calls for Repeating Clinical and Bioanalytical Studies
OTC Hearing Aids: FDA Paves the Way in its Proposed Rule
PhRMA Code Update Clarifies and Tightens Key Provisions Associated with Speaker Programs
A Target on Telehealth: Government Action Against Telehealth Fraud in the Wake of COVID-19
Latest Open Payments Data Released Under Heightened Government Scrutiny
Florida Ends Telehealth Waivers; Department of Health Issues Update
Clinical Trials: Does FDA’s Notice to Acceleron Signal a New Era of Enforcement for Results Reporting?
Sunshine Act Reporting Update: De Minimis Amounts
Blogs
Firm/Org